Product: Propantheline (bromide)
TRAIL/TNFSF10 Antibody Summary
| Immunogen |
residues [SNTLSSPNSKNE] of the N terminus of the TRAIL protein.
|
| Specificity |
Reacts with residues [SNTLSSPNSKNE] of the N terminus of the TRAIL protein.
|
| Clonality |
Polyclonal
|
| Host |
Rabbit
|
| Gene |
TNFSF10
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
||
| Application Notes |
Western blot- Use at 1:500 to 1:1,000 dilution. However, the investigator should determine the optimal dilution for a specific application such as immunohistochemistry
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
||
| Theoretical MW |
36 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
||
| Positive Control |
|
||
| Publications |
|
Reactivity Notes
Human, Mouse reactivity reported in scientific literature (PMID: 1914164).
Packaging, Storage & Formulations
| Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
|
| Buffer |
PBS
|
| Preservative |
0.02% Sodium Azide
|
| Concentration |
1 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for TRAIL/TNFSF10 Antibody
- Apo-2 ligand
- APO2L
- Apo-2Ltumor necrosis factor (ligand) family, member 10
- APO2Ltumor necrosis factor apoptosis-inducing ligand splice variant delta
- CD253 antigen
- CD253
- Protein TRAIL
- TL2
- TNF-related apoptosis-inducing ligand
- TNFSF10
- TRAIL
- TRAILTNF-related apoptosis inducing ligand TRAIL
- tumor necrosis factor (ligand) superfamily, member 10
- tumor necrosis factor ligand superfamily member 10
Background
Apoptosis or programmed cell death is induced in cells by a group of death domain containing receptors. Binding of ligand to these receptors sends signals that activate members of the caspase family of proteases. The signals ultimately cause degradation of chromosomal DNA by activating DNase. TRAIL (TNF related apoptosis induced ligand) or Apo 2L initiates apoptosis of tumor cells by binding to either of its receptors, DR4 or DR5. These receptors consist of an extracellular TRAIL binding domain and a cytoplasmic “death domain”. In addition, two decoy receptors for TRAIL have also been identified. These receptors, designated DcR1 and DcR2, lack the death domain. Binding of TRAIL to either of these receptors, therefore, does not transmit the death signal. Thus, these receptors represent a novel way of regulating cell sensitivity to a pro-apoptotic cytokine at the cell surface. TRAIL is expressed predominantly in spleen, lung, and prostate but also in many other tissues. TRAIL is a type II membrane protein from the TNF family. The human form of the protein is 281 amino acids in length, whereas the murine form is 291 amino acids. The two forms share 65% identity. Recombinant human TRAIL monomer has a molecular mass of approximately 21 kDa. Due to glycosylation, recombinant human TRAIL migrates as a 24 kDa protein in SDS PAGE.